CVS readies a set of outcomes-based contracts for its clients

While announcing its annual update of drugs (now around 36) to be excluded from its “Standard Control Formulary” in 2018, the industry-leading pharmacy benefit manager (PBM) is also hinting at another cost-control measure: outcomes-based contracting. Such programs have been occasionally entered […]

Read More

At BIO, San Diego touts its genomics breadth

The annual BIO meeting brings out economic development authorities from across the US and around the world, all pitching their locales as the preferred place to site a new lab or biotech manufacturing facility. This year, host city San Diego […]

Read More